Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Centrum Medyczne ENEL-MED S.A. (ENE.WA)
PLN19.10
+0.00 (+0.00%)
PL WSE Healthcare Medical - Care Facilities
Address
ul. Slominskiego 19 lok. 524 00-195
Warsaw, PL
Warsaw, PL
CEO
Jacek Jakub Rozwadowski
Website
enel.pl
IPO
2011-07-18
ISIN PLENLMD00017
Description
Centrum Medyczne ENEL-MED S.A., a prominent healthcare provider established in 1993, operates from its Warsaw, Poland base, offering an extensive array of medical services nationwide. These provisions encompass specialized consultations, dentistry, orthopedics, infertility treatments, physical rehabilitation, psychological support, and comprehensive diagnostic capabilities. Additionally, they provide vaccinations, emergency care, and surgical interventions to their patients.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
PLN19.10
+0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
522
Beta
0.15
Float Shares
13.67M
Free Float %
48.3%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.52% | -1.03% | +1.05% | -12.73% | +4.92% | +6.67% | -4.00% | +23.08% | -0.52% | +137.04% | +284.00% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
19.10
DCF (Unlevered)
119.36
+524.9%
DCF (Levered)
121.77
+537.6%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
0% Bullish
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 2 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
2.18
Grey zone
Piotroski F-Score
6 / 9
Average
MOAT Score
3 / 10
No MOAT
Composite Rating
B
Overall Score
3 / 5
Medium
DCF Score
5 / 5
High
ROE Score
3 / 5
Medium
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
2 / 5
Medium
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Care Facilities: +10.2%+16.1% ★ Q1'26: +15.2% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%-11.5% Q1'26: -84.4% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+1.3% Q1'26: +5.1% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+2.4% Q1'26: +3.1% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+3.3% Q1'26: +3.7% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+0.0% Q1'26: +0.0% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×3.35× Q1'26: 3.07× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
234.66M
est: 233.06M (+0.7%)
|
273.70M
est: 277.00M (-1.2%)
|
323.73M
est: 324.70M (-0.3%)
|
371.71M
est: 374.80M (-0.8%)
|
417.69M
est: 423.10M (-1.3%)
|
399.80M
est: 400.20M (-0.1%)
|
441.14M
est: 434.80M (+1.5%)
|
494.90M
est: 478.80M (+3.4%)
|
618.55M
est: 563.10M (+9.8%)
|
735.59M
est: 657.60M (+11.9%)
|
854.27M
est: 752.10M (+13.6%)
|
904.94M
904.94M – 904.94M
+20.3% YoY
|
| EBITDA |
14.12M
est: 32.18M (-56.1%)
|
20.94M
est: 38.24M (-45.2%)
|
17.82M
est: 44.83M (-60.2%)
|
23.38M
est: 51.74M (-54.8%)
|
63.06M
est: 58.41M (+7.9%)
|
70.31M
est: 55.25M (+27.2%)
|
63.32M
est: 60.03M (+5.5%)
|
40.00M
est: 66.10M (-39.5%)
|
91.11M
est: 77.74M (+17.2%)
|
105.04M
est: 83.37M (+26.0%)
|
102.06M
est: 95.35M (+7.0%)
|
114.73M
114.73M – 114.73M
+20.3% YoY
|
| EBIT |
2.59M
est: 3.45M (-25.0%)
|
4.54M
est: 4.11M (+10.5%)
|
-1.75M
est: 4.81M (-136.3%)
|
2.21M
est: 5.55M (-60.3%)
|
6.00M
est: 6.27M (-4.4%)
|
13.37M
est: 5.93M (+125.4%)
|
5.85M
est: 6.44M (-9.2%)
|
-22.13M
est: 7.10M (-411.8%)
|
19.71M
est: 8.35M (+136.2%)
|
29.57M
est: 8.49M (+248.1%)
|
20.43M
est: 9.72M (+110.3%)
|
11.69M
11.69M – 11.69M
+20.3% YoY
|
| Net Income |
557.0K
est: 3.98M (-86.0%)
|
1.83M
est: 1.98M (-7.4%)
|
-3.31M
est: 848.4K (-489.7%)
|
-735.0K
est: -848.4K (+13.4%)
|
-2.47M
est: 1.41M (-274.5%)
|
-3.40M
est: -5.37M (+36.8%)
|
-1.41M
est: 1.70M (-183.1%)
|
-23.56M
est: 5.94M (-496.7%)
|
8.23M
|
14.61M
|
12.89M
est: 3.61M (+256.9%)
|
10.73M
10.73M – 10.73M
+196.9% YoY
|
| SGA |
17.17M
est: 13.15M (+30.6%)
|
17.47M
est: 15.63M (+11.8%)
|
20.16M
est: 18.32M (+10.1%)
|
22.10M
est: 21.14M (+4.5%)
|
20.24M
est: 23.87M (-15.2%)
|
20.23M
est: 22.58M (-10.4%)
|
23.81M
est: 24.53M (-2.9%)
|
37.12M
est: 27.01M (+37.4%)
|
33.51M
est: 31.77M (+5.5%)
|
35.54M
est: 39.48M (-10.0%)
|
58.71M
est: 45.15M (+30.0%)
|
54.33M
54.33M – 54.33M
+20.3% YoY
|
| EPS |
0.02
est: 0.14 (-85.8%)
|
0.07
est: 0.07 (+0.0%)
|
-0.14
est: 0.03 (-566.7%)
|
-0.03
est: -0.03 (-4.0%)
|
-0.10
est: 0.05 (-300.0%)
|
-0.14
est: -0.19 (+26.3%)
|
-0.06
est: 0.06 (-197.7%)
|
-0.83
est: 0.21 (-495.2%)
|
0.29
|
0.52
|
0.46
est: 0.13 (+260.1%)
|
0.38
0.38 – 0.38
+196.9% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-26 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-25 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-22 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-21 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-20 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-19 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-18 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-15 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-14 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-13 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-12 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-11 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-08 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-07 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-06 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-05 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-04 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-30 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-29 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-28 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-27 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-24 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-23 | B+ | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-22 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-21 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-20 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-17 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-16 | B | 3/5 | 5/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
94.56M
OE per share TTM
3.34
Owner's Yield
17.41%
Maintenance CapEx ratio
927.33%
Maint CapEx / Avg PPE
66.7%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
No insider activity available.
Insider buys vs sells (history)
Insider history not available.
Recent insider transactions
No recent insider transactions.
Executive team
Top executives
EBIT / Employee
4.9K
Shares Outstanding
28.28M
Executive compensation
Executive compensation (annual)
Executive compensation not available.
CEO compensation breakdown
No CEO compensation history available.
Proxy statements
Proxy statements (DEF 14A)
No proxy statements available for this company yet.
Recent SEC filings
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jacek Jakub Rozwadowski | President of Management Board, MD & Chief Executive Officer | 761.0K | male |
| Bartosz Adam Rozwadowski | Director of Investments & Procurement and Member of the Management Board | 410.0K | male |
| Zaneta Bujalska | Chief Accountant | — | female |
ESG Score History
No data available for this company.
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for ENE.WA
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
